Global Ophthalmic Drugs Market Forecast 2018-2028 - Visiongain Report

USA - English

• USA - English

LONDON, July 2, 2018 /PRNewswire/ --

Dry Eye, Glaucoma Drugs, Retinal Disorders Drugs and Allergic, Inflammatory & Infective Drugs 

The global ophthalmic drugs market is expected to grow at a CAGR of 4.4% in the first half of the forecast period. The market is expected to grow at a CAGR of 4.8% from 2017-2028. The market is estimated at $24bn in 2017, dominated by the retinal disorder drugs segment.

     (Logo: http://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg )

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 298-page report you will receive 123 tables and 113 figures- all unavailable elsewhere.

The 298-page report provides clear detailed insight into the global ophthalmic drugs market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope 

• Global Ophthalmic Drugs market forecasts from 2017-2028

• This report also breaks down the revenue forecasts to 2028 for the global ophthalmic drugs market by the leading submarkets:
• Retinal Disorder Drugs
• Allergic, Inflammatory & Infective Drugs
• Glaucoma Drugs
• Dry Eye Drugs
• Other Ophthalmic Drugs

• This report includes revenue forecasts to 2028 for the following ophthalmic drugs:
• Eylea
• Lucentis
• Avastin
• Visudyne
• Jetrea
• Pataday
• Vigamox
• Patanol
• TobraDex
• Cravit
• AzaSite
• Acular
• Lumigan and Ganfort
• Xalatan/Xalacom
• Travatan/Travatan Z and DuoTrav
• Alphagan/Alphagan P and Combigan
• Azopt
• Trusopt
• Zioptan
• Cosopt
• Tapros/Taflotan
• Restasis
• Refresh
• Hyalein
• Diquas

• This report provides individual revenue forecasts to 2028 for these national markets:
• The US
• Japan
• EU5: Germany, France, the UK, Spain, Italy
• Russia
• China
• India
• Brazil
• Rest of the World

• Our study provides a SWOT analysis and discusses Porter's Five Forces analysis that influence the global ophthalmic drugs market

• Our report provides discussion on the ophthalmic drugs that are currently in the development pipeline

• Our study discusses the selected leading companies that are the major players in the ophthalmic drugs industry:
• Novartis
• Regeneron
• Allergan
• Roche
• Valeant
• Santen
• Bayer
• Pfizer
• Senju

Visiongain's study is intended for anyone requiring commercial analyses for the global ophthalmic drugs market. You find data, trends and predictions.

Buy our report today Global Ophthalmic Drugs Market Forecast 2018-2028: Dry Eye, Glaucoma Drugs, Retinal Disorders Drugs and Allergic, Inflammatory & Infective Drugs.

To request a report overview of this report please contact Sara Peerun at [email protected] or refer to our website : https://www.visiongain.com/report/global-ophthalmic-drugs-market-forecast-2018-2028

Acucela
Actavis
Advanced Cell Technologies
Aerie Pharmaceuticals
Aerpio Therapeutics
Alcon
Alembic
Algeta
Alimera Sciences
Allegro
Allergan
Akorn
Amakem
Amgen
Ampio Pharmaceuticals
Apotex
Asahi Glass
AstraZeneca
Aurobindo Pharma Ltd
Aventis
Barr Laboratories
Bausch & Lomb
Biocad
BioDiem
Biovail Corporation
BioXpress Therapeutics
Bristol-Myers Squibb
Can-Fite BioPharma 
Cipla
Chengdu Kanghong Pharmaceutical
Chiesi Farmaceutici S.p.A
Chiron Corporation
Chugai Pharmaceutical
CIBA VISION
Colby Pharmaceuticals
Daiichi Sankyo
Eleven Biotherapeutics
Eli Lilly
ESBATech
EyeCyte
EyeGate
Eyetech Pharmaceuticals
ForeSight Biotherapeutics
ForSight VISION4
Fougera Pharmaceuticals
Gene Signal
Genentech
GlaxoSmithKline
Hospira
iCo Therapeutics
Icon Bioscience
InSite Vision
Inspire Pharmaceuticals
Instituto Terapeutico Delta Ltda
Jenapharm
Johnson & Johnson
Kala Pharmaceuticals
KalVista
Kestrel Ophthalmics
Kyorin Pharmaceutical
Kyowa Hakko Kirin
LEO Pharma
Lpath
MacuCLEAR
MacuSight
MAP Pharmaceuticals
MEAgate International FZLLC
Meda
Merck & Co. (Merck)
MerLion
Molecular Partners
MSD K.K.
Neurim Pharmaceuticals
Neurotech
Nicox SA
NovaBay
Novagali
Novartis
Novel Labs Inc
OHR Pharmaceutical
Omeros
OphthaliX
Ophthotech
PanOptica
Patheon Pharmaceuticals
Par Pharmaceutical
Pfizer
Pharmacia
PreCision Dermatology
Procter & Gamble
pSivida
QLT
Quark Pharmaceuticals 
Regeneron
Reckitt Benckiser
Roche
Roche Consumer Health
R-Tech Ueno
RXi Pharmaceuticals
Salix
Sanofi
Sandoz
Santaris Pharma
Santen
Schering AG
Seikagaku
Senju
Servier
Shire
SkinMedica
Sobi
Stelgerwald
Spark Therapeutics
Takeda
ThromboGenics
Upjohn
UV North America
Valeant
Vanda Pharmaceuticals
Ventana Medical Systems
Warburg Pincus LLC
Watson
Wockhardt
Wyeth Pharmaceuticals
Zach System Spa

To see a report overview please e-mail Sara Peerun on [email protected]